Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-21

Clinical Trial Update: A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing LY3305677 to placebo in adults with obesity or overweight has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY3305677 (LY3305677)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity, Overweight and Obesity | Phase 2 | Status: COMPLETED | Results posted: 2026-04-21